Source: Techworld

Exscientia: Exscientia CEO explains how AI is transforming drug discovery

Andrew Hopkins, CEO of Exscientia, tells Techworld how his company's system dramatically reduces the time and costs involved in discovering new medicines

Read full article »
Exscientia's Competitors | Exscientia's News | Exscientia's Financials
Stay up-to-date with the latest news on Exscientia
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Andrew Hopkins's photo - Founder & CEO of Exscientia

Founder & CEO

Andrew Hopkins

CEO Approval Rating

81/100

Read more
Stay up-to-date with the latest news on Exscientia